Clinical Trial Update: Investigation of the Safety of Intranasal Glulisine in Down Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the safety of intranasal glulisine in individuals with Down syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• glulisine (glulisine)

Snippet

Sponsor: HealthPartners Institute | Conditions: Down Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2019-12-06